Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001613377-16-000018
Filing Date
2016-05-03
Accepted
2016-05-03 15:21:15
Documents
1
Period of Report
2016-04-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 4253
  Complete submission text file 0001613377-16-000018.txt   5670
Mailing Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103 215-988-0080
HEMISPHERX BIOPHARMA INC (Issuer) CIK: 0000946644 (see all company filings)

EIN.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 17400 STERLING LAKE DRIVE FORT MYERS FL 33967
Business Address
Rodino Peter W. III (Reporting) CIK: 0001583701 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-27072 | Film No.: 161615154